PDCoV nsp5 inhibits type I IFN production by means of its protease activity. PDCoV nsp5 cleaves NEMO to disrupt RIG-I/MDA5 signaling. PDCoV nsp5 recognizes Q231 of NEMO as the P1 position for cleavage. The cleaved NEMO products fail to induce the transcription of ISGs.